Medication info
Esomezol Capsule 40mg (Esomeprazole Strontium Trihydrate)

Esomezol Capsule 40mg (Esomeprazole Strontium Trihydrate)

Prescription medicationHard capsule
Ingredient · strength
Esomeprazole Strontium Tetrahydrate›49.3mg / 1 capsule
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
A light pink hard capsule containing white to light brown granules
Packaging
30 capsules/bottle, 100 capsules/bottle
Approval status
Active

MFDS item code 200711655 · Notified 2007.10.24 · Insurance code 643501850

Summary

Main use
Treatment of gastroesophageal reflux, gastrointestinal disorders (ulcers, Helicobacter pylori, etc.), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this drug 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical studies exceeding 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue for as long as clinically indicated. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following intravenous treatment to induce prevention of rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous treatment to induce prevention of rebleeding from gastric or duodenal ulcers. 4. Renal impairment : No dose adjustment is necessary. Use with caution because there is limited experience administering this drug to patients with severe renal impairment. 5. Hepatic impairment : No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this drug. 6. Elderly patients : No dose adjustment is necessary.
Children's dosage
2. Adolescents 12 years of age and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. 3. Children under 12 years of age : There is no experience with administering this drug to children under 12 years of age.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux, gastrointestinal disorders (ulcers, Helicobacter pylori, etc.), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
  • rebleeding
View approved original text

This medicine is used for the treatment of gastroesophageal reflux disease, particularly erosive reflux esophagitis, and for long-term maintenance therapy to prevent recurrence in patients. It also helps in the treatment and prevention of recurrence in patients with duodenal ulcers and peptic ulcers infected with Helicobacter pylori. It is effective for short-term treatment of gastrointestinal symptoms that may occur with the use of nonsteroidal anti-inflammatory drugs and is also used for the treatment and prophylaxis of gastric ulcers and duodenal ulcers. It is suitable for the treatment of Zollinger-Ellison syndrome and is used as maintenance therapy after preventing rebleeding due to gastric or duodenal ulcers. Thus, it is widely used for various gastrointestinal diseases and symptoms.

Dosage and Administration

Adult dosage

1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this drug 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical studies exceeding 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue for as long as clinically indicated. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following intravenous treatment to induce prevention of rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous treatment to induce prevention of rebleeding from gastric or duodenal ulcers. 4. Renal impairment : No dose adjustment is necessary. Use with caution because there is limited experience administering this drug to patients with severe renal impairment. 5. Hepatic impairment : No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this drug. 6. Elderly patients : No dose adjustment is necessary.

Children's dosage

2. Adolescents 12 years of age and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. 3. Children under 12 years of age : There is no experience with administering this drug to children under 12 years of age.

Precautions

This medication should not be used in patients with known allergies to specific drugs or components. Caution is particularly necessary in cases of hypersensitivity to benzimidazole derivatives, penicillin antibiotics, and macrolide antibiotics. Additionally, it may pose risks when taken with certain heart-related medications or antivirals; therefore, consultation with a physician is required. It is safer for nursing women to avoid taking this medication. This drug contains a pigment called Yellow No. 5, so individuals allergic to this component should use cautiously. Various side effects may occur during treatment, and if abnormal symptoms like headaches, dizziness, abdominal pain, or skin rashes arise, immediate consultation with a physician is necessary. Regular checks are needed during long-term use, and caution is warranted in osteoporotic patients due to an increased risk of fractures. This medication can reduce stomach acid, which may promote bacterial proliferation in the gastrointestinal tract, so if symptoms of infection like diarrhea occur, healthcare personnel should be informed. As there are numerous drug interactions, it is vital to inform your physician or pharmacist about any medications currently taken. The safety of this medication during pregnancy has not been fully confirmed; thus, it should be taken under a doctor's guidance, and it is advisable to avoid taking it while nursing. In the case of overdose, as there are no specific antidotes available, appropriate treatment should be sought immediately at a hospital. This medication should be stored out of the reach of children and should not be kept in a changed container.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized pustular psoriasis, eosinophilia and drug reaction with systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile infection, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, peripheral edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid swelling, irritable bowel syndrome, exacerbation of constipation, indigestion, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin levels, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, ear pain, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, cramps, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, loss of appetite, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory disturbances, taste loss, taste alterations, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain storage temperature between 1 to 30 degrees Celsius to ensure the drug's effectiveness is safely preserved.

Appearance and packaging

Appearance

A light pink hard capsule containing white to light brown granules

Package unit

30 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.